Kavita Diddi
Prime Healthcare Group, UAE
Title: Multidrug Resistant Organisms (MDROs) screening in ICUs: Required or not?
Biography
Biography: Kavita Diddi
Abstract
Healthcare-associated infection leads to an increase in hospital stay and cost. There are different measures recommended by various international associations to reduce the incidence of healthcare associated infections. There is no consensus regarding the pre-screening of multidrug resistance organisms at the time of admission. After the literature review, it was found that screening of Multidrug-Resistant Organisms (MDROs) will be beneficial in high-risk patients. In our hospital prevalence of methicillin-resistant Staphylococcus aureus (MRSA) is approximately 28%, on this basis we started screening for methicillin-resistant Staphylococcus aureus in all the patients getting admitted in ICU. We found 6 patients out of 21 screened (29%) were a carrier for MRSA in one month. In conclusion, the decision to start pre-screening for MDRs should take based on the local prevalence of organisms.